JourneyMark review

It depends on the buyer's time horizon and goals. For someone who has true long-term money, is comfortable with participation-rate mechanics, and wants the option to bolt on income protection without switching products, JourneyMark is a reasonable choice backed by a strong carrier. For someone who needs flexibility inside ten years, wants a simple capped-index design, or is mainly shopping for guaranteed income, this is not the right fit.

The rational case for JourneyMark is the combination of cap-free crediting and a respected carrier at a low minimum premium. Many 10-year FIAs use cap rates that can be reset lower over time; JourneyMark instead uses participation rates that have contractual minimums — the S&P 500 annual floor is 4%, and the proprietary indices carry 10% minimums. That means the worst-case participation rate is spelled out in the contract, not just set by the insurer each year. The Expanse Rider's 10% benefit-base bonus and 200% roll-up (up to the 25% annual cap) can also make the income option look meaningful for buyers who want a fallback if their health changes.

I think JourneyMark is best for buyers in their mid-50s to early 70s who are setting aside qualified or non-qualified dollars they do not expect to touch for a decade. The wide issue-age range (0–85) means it can fit non-traditional use cases, but the 10-year surrender schedule is genuinely punishing in the early years, so it works best when the time horizon is aligned. Buyers who want the income rider should understand that the Expanse Rider adds a 1% fee on the benefit base starting at issue, not only after income turns on, so the clock on that cost starts immediately.

You are buying an insurance contract that credits interest based on the performance of outside indices — not direct market participation. When the index goes up, a fraction of that gain (the participation rate) is credited to your account; when the index goes down, you receive zero, not a loss. The floor is zero. The ceiling is not a fixed cap rate here — it is the index return multiplied by the participation rate. That is the fundamental trade: you give up some upside and accept a 10-year surrender period in exchange for downside protection and the participation structure. The MVA is an additional factor: if you surrender early when interest rates have risen since you bought the contract, the market value adjustment can reduce your surrender proceeds below what the schedule alone would suggest.

JourneyMark uses participation-rate-only crediting across all indexed options — there are no cap rates anywhere in the product. The index menu includes the S&P 500, the Citi Flexi-Beta 5 Excess Return Index, Goldman Sachs Pathfinder, and Goldman Sachs Mariner. Crediting terms range from annual point-to-point to biennial term-end-point to a 5-year quarterly high-water-mark strategy.

The S&P 500 annual participation rate of 41% (minimum 4%) is the most familiar reference point — it means 41 cents of every dollar of S&P 500 gain is credited to the account. The proprietary indices are different animals. Citi Flexi-Beta 5 runs at 162% annual participation (minimum 10%), which means if that index gains 5%, more than 8% is credited. These volatility-controlled indices are designed with lower raw volatility than the S&P 500, and the insurer offers higher participation rates in exchange — more of a smaller swing. The 5-year quarterly high-water-mark strategy on Citi Flexi-Beta 5 runs at 222%, measuring the highest quarterly value over the five-year term. Buyers should not assume the proprietary indices will outperform the S&P 500 in every environment — the high participation rates compensate for the indices' more modest absolute-return histories.

The optional Expanse Rider is the secondary feature worth understanding. It adds a GLWB — a guaranteed lifetime withdrawal benefit — that gives a retirement-income floor without annuitizing the contract. The rider applies a 10% benefit-base bonus to each premium payment at issue, and the benefit base grows at 200% of the interest credited to the account value (up to a 25% annual cap) for up to 15 years before income starts. The 1.00% annual fee comes off the benefit base, not the account value, which affects how the math works over time.

Two other Expanse Rider features matter: the free-withdrawal allowance increases from 5% to 10% with the rider in force, and before income activation, the death benefit steps up to 120% of account value. There is also an Income Doubler — if you become unable to perform two of six activities of daily living, the lifetime payment amount doubles. That makes the Expanse Rider a multi-function add-on rather than a pure income play.

JourneyMark is a 10-year commitment. The base free-withdrawal provision after the first index year is 5% of beginning-of-index-year account value — noncumulative and not compounding. With the Cascade or Expanse Rider, that allowance rises to 10%. RMDs that exceed the free-withdrawal amount in a given index year are waived from surrender charges and MVA (one waiver per index year). Substantially equal periodic payments under IRC 72(t) and 72(q) are also waived.

The MVA — Market Value Adjustment — is worth understanding clearly. When interest rates rise after you purchase the contract and you take a withdrawal subject to the surrender charge, the MVA can reduce your proceeds further. This is separate from and in addition to the withdrawal charge. California operates under a modified schedule (9-year MVA period with a different charge table), so CA buyers should review those terms specifically.

Confinement and terminal illness waivers are available in most states (not California) if you are confined for 60 or more consecutive days in a qualified care facility or receive a diagnosis of 12 months or fewer to live. These are meaningful safety valves, but they do not transform this into a liquid contract.

There is no base contract fee on JourneyMark. The Expanse Rider costs 1.00% annually of the benefit base. The Cascade Rider (a separate GMAV/accumulation rider mentioned in the brochure) costs 1.00% annually on the 10-year product or 0.35% on the 7-year version. These fees are charged regardless of how well the indices perform.

The structural tradeoffs are the more important story. Cap-free participation-rate crediting is not free money — the participation rates are reset periodically, and while the contractual minimums provide a floor, the actual credited rate depends on a formula the insurer controls. The proprietary indices have embedded index costs (reflected in the index construction rather than charged separately) that reduce their raw return before the participation rate is applied. And the combination of a 10-year surrender schedule plus an MVA means any mid-contract liquidity need can be genuinely costly in a rising-rate environment.

Legal Entity: Integrity Life Insurance Company

Parent: Western & Southern Financial Group

AM Best Rating: A+

Western & Southern is one of the more financially durable life insurance groups in the country — the A+ AM Best rating reflects a strong balance sheet and long operating history. Integrity Life Insurance Company is the issuing entity, and buyers should make sure their purchase documentation lists Integrity Life specifically.